Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 8, 2003, Pages 622-628

  Hsu, Lewis L ^a   Miller, Scott T ^b   Wright, Elizabeth ^d   Kutlar, Abdullah ^c   McKie, Virgil ^c   Wang, Winfred ^e   Pegelow, Charles H ^f   Driscoll, Catherine ^g   Hurlet, Anne ^h   Woods, Gerald ⁱ   Elsas, Louis ^a,f   Embury, Stephen ^j   Adams, Robert J ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ CHILDREN S MERCY HOSPITAL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Alpha thalassemia; Cerebrovascular disease; Children; Hematocrit; Ranscranial Doppler ultrasound; Risk factor; Sickle cell; Stroket

Indexed keywords

ALPHA GLOBIN;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; CELL SIZE; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE SHAPE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTECTION; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; STROKE;

ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 0042570486     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200308000-00007     Document Type: Article

References (38)

1. Adams RJ, McKie V, Nichols FT, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605-610.
2. Serjeant GR, Grandison Y, Lowrie Y, et al. The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years. Br J Haematol. 1981;48:533-543.
3. Piomelli S, Paik M, Scaman C, et al. Concomitant alpha thalassemia reduces the odds of stroke in HgbSS disease. 18th Annual Meeting of the National Sickle Cell Disease Program, 1993; p142a.
4. Adams RJ, Kutlar A, McKie V, et al. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994;45:279-282.
5. Figueiredo MS, Kerbauy J, Goncalves MS, et al. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996;53:72.
6. Neonato MG, Guilloud-Bataille M, Beauvais P, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol. 2000;65:155-164.
7. Sarniak SA, Ballas SK. Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am J Hematol. 2001;67:179-182.
8. Miller ST, Rieder RF, Rao SP, et al. Cerebrovascular accidents in children with sickle-cell disease and alpha-thalassemia. J Pediatr. 1988;113:847-849.
9. Dozy AM, Kan YW, Embury SH, et al. Alpha-globin gene organisation in blacks precludes the severe form of alpha-thalassaemia. Nature. 1979;280:605-607.
10. Steinberg MH. Modulation of the phenotypic severity of sickle cell anemia. Hemoglobin. 1996;20:1-19.
11. Higgs DR, Aldridge BE, Lamb J, et al. The interaction of alpha thalassemia and homozygous sickle cell disease. N Engl J Med. 1982;306:1441-1446.
12. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
13. Bernaudin F, Verlhac S, Freard F, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15:333-343.
14. Adams RJ, McKie VC, Hsu LL, et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial ultrasonography. N Engl J Med. 1998;339:5-11.
15. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998;19:110-129.
16. Kutlar F, Milner P, McKie KM, et al. A new approach to the detection of -a3.7 deletion by PCR. 21st Annual Meeting of the National Sickle Cell Disease Program, Mobile, AL. March 6-9, 1996; p31.
17. Guasch A, Zayas CF, Eckman JR, et al. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999;10:1014-1019.
18. Embury SH, Miller JA, Dozy AM, et al. Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype. J Clin Invest Dec. 1980;66:1319-1325.
19. Embury SH, Dozy AM, Miller J, et al. Concurrent sickle cell anemia and alpha-thalassemia: Effect on severity of anemia. N Engl J Med. 1982;306:270-274.
20. Adams RJ, Nichols FT, Hess DC. Normal values and physiological variables. In: Newell D, Aaslid R, eds. Transcranial Doppler. New York: Raven Press, 1992:41-48.
21. Venketasubramanian N, Prohovnik I, Hurlet A, et al. Middle cerebral artery velocity changes during transfusion in sickle cell anemia. Stroke. 1994;25:2153-2158.
22. Muhling I, Dehne MG, Sablotzki A, et al. Cerebral blood flow velocity during isovolemic hemodilution and subsequent autologous blood retransfusion. Can J Anaesth Jun. 1999;46:550-557.
23. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000;342:9-14.
24. Fiermonte G, Aloe Spiriti MA, Latagliata R, et al. Polycythaemia vera and cerebral blood flow: a preliminary study with transcranial Doppler. J Intern Med. 1993;234:599-602.
25. Gruber EM, Jonas RA, Newburger JW, et al. The effect of hematocrit on cerebral blood flow velocity in neonates and infants undergoing deep hypothermic cardiopulmonary bypass. Anesth Analg. 1999;89:322-327.
26. Schuurman PR, Albrecht KW. Intraoperative changes of transcranial Doppler velocity: relation to arterial oxygen content and whole-blood viscosity. Ultrasound Med Biol. 1999;25:151-154.
27. Hata R, Matsumoto M, Handa N, et al. Effects of hemodialysis on cerebral circulation evaluated by transcranial Doppler ultrasonography. Stroke. 1994;25:408-412.
28. Braden DS, Covitz W, Milner PF. Cardiovascular function during rest and exercise in patients with sickle-cell anemia and coexisting alpha thalassemia-2. Am J Hematol. 1996;52:96-102.
29. Embury SH, Clark MR, Monroy G, et al. Concurrent sickle cell anemia and alpha thalassemia: Effect on pathologic properties of sickle erythrocytes. J Clin Invest. 1984;73:16-23.
30. Bunyaratvej A, Fucharoen S, Butthep P, et al. Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia. Southeast Asian J Trop Med Pub Health. 1995;26(Suppl 1):257-260.
31. Asakura T, Minakata K, Adachi K, et al. Denatured hemoglobin in sickle erythrocytes. J Clin Invest. 1977;59:633-640.
32. Ballas SK, Burka ER. Catabolism of hemoglobin by human erythrocyte membranes. J Lab Clin Med. 1978;92:387-392.
33. Shartava A, Monteiro CA, Benesath FA, et al. A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells. J Cell Biol. 1995;128:805-818.
34. Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998;91:3044-3051.
35. Takenaka K, Kassell NF, Foley PL, et al. Oxyhemoglobin-induced cytotoxicity and arichidonic acid release in cultured bovine endothelial cells. Stroke. 1993;24:839-845.
36. McLeod LL, Alayash AI. Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am J Physiol. 1999;277: H92-H99.
37. Meguro T, Klett CP, Chen B, et al. Role of calcium channels in oxyhemoglobin-induced apoptosis of endothelial cells. J Neurosurg. 2000;93:640-646.
38. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.